These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7296970)

  • 41. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
    Vierhapper H; Dudczak R; Waldhäusl W
    Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonidine reduces elevated cerebrospinal fluid catecholamine levels in patients with essential hypertension.
    Cubeddu LX; Hoffmann IS; Davila J; Barbella YR; Ordaz P
    Life Sci; 1984 Sep; 35(13):1365-71. PubMed ID: 6482658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of chronic administration of clonidine, propranolol and alpha-methyldopa on extensibility and biochemical properties of the veins in renal and spontaneous hypertension.
    Greenberg S
    J Pharmacol Exp Ther; 1981 Sep; 218(3):779-90. PubMed ID: 7264961
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma catecholamines in long-term diabetes.
    Cordes U; Beyer J; von Ungern-Sternberg A
    Horm Metab Res Suppl; 1980; 9():90-3. PubMed ID: 6929784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha 1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure.
    Fadda GZ; Massry SG; el-Refai M; Campese VM
    Kidney Int; 1988 Oct; 34(4):463-6. PubMed ID: 2848971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of antihypertensive drugs on the synthesis and metabolism of prostaglandins.
    Taube C; Pönicke K; Heinroth I; Block HU; Mentz P; Förster W
    Acta Biol Med Ger; 1976; 35(8-9):1227-8. PubMed ID: 1007782
    [No Abstract]   [Full Text] [Related]  

  • 47. [Centrally acting antihypertensive agents (author's transl)].
    Elghozi JL; Grünfeld JP
    Therapie; 1982; 37(2):163-9. PubMed ID: 7112486
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of antihypertensive therapy with clonidine and alphamethyldopa on the indirect oxygen consumption index of the myocardium at rest and during exertion].
    Sau F; Mercuro G; Seguro C; Bonomo P; Cherchi A
    Cardiologia; 1985 Feb; 30(2):113-9. PubMed ID: 4064063
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chrono-pharmacodynamics of hypotensive preparations].
    Zaslavskaia RM; Varshitskiĭ MG; Vilkovyskiĭ FA; Olevskiĭ IKh; Teĭblium MM
    Klin Med (Mosk); 1989 Jan; 67(1):63-7. PubMed ID: 2716255
    [No Abstract]   [Full Text] [Related]  

  • 50. METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.
    LUKE RG; KENNEDY AC
    Br Med J; 1964 Jan; 1(5374):27-30. PubMed ID: 14071629
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood hydrocarbazine concentration in normal subjects and patients having chronic renal insufficiency].
    Fillastre JP; Bieder A
    Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):472-85. PubMed ID: 5807179
    [No Abstract]   [Full Text] [Related]  

  • 52. [1-alphamethyldopa against racemic form. A comparative study on the effect of hypotensive agents].
    Alestig K; Sannerstedt R
    Lakartidningen; 1965 Aug; 62(34):2662-7. PubMed ID: 5330285
    [No Abstract]   [Full Text] [Related]  

  • 53. [CATECHOLAMINES AND HYPOTENSIVE THERAPY].
    BARTHOLINI G
    G Clin Med; 1963 Mar; 44():247-89. PubMed ID: 14302605
    [No Abstract]   [Full Text] [Related]  

  • 54. Antihypertensive therapy in chronic renal failure.
    Maschio G
    Saudi J Kidney Dis Transpl; 1999; 10(3):275-8. PubMed ID: 18212436
    [No Abstract]   [Full Text] [Related]  

  • 55. Antihypertensive therapy and progression of renal failure.
    Segura J; Campo C; Ruilope LM
    Saudi J Kidney Dis Transpl; 2002; 13(3):266-72. PubMed ID: 18209423
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sympathetic activity in terminal renal failure and kidney transplants].
    Lang R; Michels J; Becker-Berke R; Lukowski K; Vlaho V; Grundmann R
    Klin Wochenschr; 1984 Nov; 62(21):1025-31. PubMed ID: 6392724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of antihypertensive therapy on plasma catecholamines in renal failure patients.
    Henrich WL; Mitchell H; Anderson S; Cronin R; Pettinger WA
    Clin Nephrol; 1981 Sep; 16(3):131-6. PubMed ID: 7296970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: effects of clonidine.
    Izzo JL; Santarosa RP; Larrabee PS; Smith RJ; Kallay MC
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S225-9. PubMed ID: 2455184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal.
    Cubeddu LX; Hoffman IS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S205-10. PubMed ID: 2455180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.